Page 1 of 1

Positive phase 2 study results for TheraVidas'a THVD-102

Posted: Sun Mar 05, 2017 8:10 pm
by admin
THVD-102 is a new proprietary oxybutynin 7.5mg plus pilocarpine 7.5mg combination product manufactured by TheraVida:

https://www.businesswire.com/news/home/ ... erhidrosis